Details

Financial toxicity among cancer patients in Slovenia
ID Skubic, Marjeta (Author), ID Vöröš, Katja (Author), ID Bavdaž, Mojca (Author), ID Došenović Bonča, Petra (Author), ID Perhavec, Andraž (Author), ID Redek, Tjaša (Author), ID Ratoša, Ivica (Author), ID Zobec Logar, Helena Barbara (Author)

.pdfPDF - Presentation file, Download (543,11 KB)
MD5: 00BECCB5D702B51D935BB8F267D65016
URLURL - Source URL, Visit https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.70891 This link opens in a new window

Abstract
Background: The ageing population, increasing medical costs and a number of newly diagnosed cancer cases among the working population are increasing the financial burden on healthcare systems. The extent of financial toxicity in Slovenian patients has been insufficiently researched, as has its impact on quality of life (QoL). Methods: To evaluate financial toxicity, the Functional Assessment of Chronic Illness Therapy (COST-FACIT) questionnaire was translated into Slovenian, validated, introduced and compared with the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30). Additional questions were incorporated into the questionnaire to further quantify and objectify financial toxicity. The study was cross-sectional. The statistical analysis was based on descriptive and inferential statistics and exploratory data analysis. Results: Out of 590 analysed participants, financial toxicity was absent in 57.2% but present at mild to moderate levels in 42.8%. Key risk factors included lower income, age ≤ 65, employment, active oncologic treatment, rural residence and religious affiliation. Post hoc analyses showed higher financial toxicity in those with ≤ 600 EUR monthly income, employed patients and spiritual individuals, while cancer type showed no significant differences. The correlation between financial toxicity and QoL was mild. Objective measures of financial toxicity include direct costs (e.g., transportation, supplements and medical devices) and indirect costs (e.g., loss of income) associated with disease and treatment, which burdened more than 40% of the studied population. Conclusions: The COST-FACIT proved to be a helpful screening tool for identifying patients at risk, even in a public healthcare system such as the Slovenian system. On average, financial toxicity is low due to the publicly funded financial system covering the treatment and rehabilitation of malignant diseases. The age structure of cancer patients and secure pension income further contribute to this outcome.

Language:English
Keywords:cancer burden, cancer patients, COST-FACIT, EORTC QLQ-C30, financial burden, financial toxicity, quality of life
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:EF - School of Economics and Business
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:13 str.
Numbering:Vol. 14, iss. 8, article no. e70891
PID:20.500.12556/RUL-172604 This link opens in a new window
UDC:614
ISSN on article:2045-7634
DOI:10.1002/cam4.70891 This link opens in a new window
COBISS.SI-ID:234081539 This link opens in a new window
Publication date in RUL:09.09.2025
Views:194
Downloads:98
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Cancer medicine
Publisher:John Wiley & Sons Ltd
ISSN:2045-7634
COBISS.SI-ID:519144729 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:zdravstvo, bolezni, onkološki bolniki, finančna stiska, življenjski stroški

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P5-0128-2018
Name:Izzivi vključujočega in trajnostnega razvoja v prevladujoči paradigmi ekonomskih in poslovnih znanosti

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P5-0441-2023
Name:Regeneracija ekonomije in posla

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P5-0117-2018
Name:Trajnostna konkurenčnost slovenskega gospodarstva v evropskem in globalnem okviru

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4575
Name:J7-4575

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back